Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
about
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetesTargeting metabolic disturbance in the diabetic heart.The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats.Age and Smoking Related Changes in Metal Ion Levels in Human Lens: Implications for Cataract FormationHistone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.The Features of Copper Metabolism in the Rat Liver during DevelopmentA novel nano-copper-bearing stainless steel with reduced Cu(2+) release only inducing transient foreign body reaction via affecting the activity of NF-κB and Caspase 3.Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.Dissecting copper homeostasis in diabetes mellitus.Deficient copper concentrations in dried-defatted hepatic tissue from ob/ob mice: A potential model for study of defective copper regulation in metabolic liver disease.Rutin administration attenuates myocardial dysfunction in diabetic rats.New Insight in Copper-Ion Binding to Human Islet Amyloid: The Contribution of Metal-Complex Speciation To Reveal the Polypeptide Toxicity.Effect of different glycation agents on Cu(II) binding to human serum albumin, studied by liquid chromatography, nitrogen microwave-plasma atomic-emission spectrometry, inductively-coupled-plasma mass spectrometry, and high-resolution molecular-massEvidence for widespread, severe brain copper deficiency in Alzheimer's dementia.Chelation for diabetes complications: A neglected approach?
P2860
Q35073993-A5A35D97-EF5B-474A-9845-D3BED30FEA2FQ35084845-5D5E6CFE-E676-49F6-B6E0-FCABF067D429Q35842699-FE995E9E-D06A-4A0B-B01C-33FA217E416EQ35900004-B21F924F-6767-4061-A92E-476BB694A02FQ35922922-A17EA0B6-CD3C-4C06-8F4C-09F76588780EQ36170780-3342E45E-1EBD-49FE-AD3C-32C6640C959BQ36244280-95945AD2-3819-4C28-8621-B7F582FF1FD7Q36985886-55E59CD8-65CD-4638-9C1E-F20FA637D8FCQ39169920-0A9D3215-B38C-4801-B689-82F9BCD5F672Q40526960-9391C632-4459-4087-A9FA-97810931705DQ41713255-B3E40B85-65F7-4EF9-A25B-7CCC4E72922CQ46506077-0044A5D5-F57A-478E-AC5C-ECFAF491B6C7Q46809856-4FF9AD03-72B3-4111-969F-78B7A639A302Q47683018-72D035ED-E23A-43DD-8DF0-1AB0EAE3149DQ53705068-54C7F119-8D53-4D40-9106-9B1F6C199C63
P2860
Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@ast
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@en
type
label
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@ast
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@en
prefLabel
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@ast
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@en
P2093
P2860
P356
P1476
Diabetic cardiomyopathy is ass ...... d by divalent copper chelation
@en
P2093
Anthony R J Phillips
Bernard Barry
Carlos C H Cheung
Deming Gong
Garth J S Cooper
Greeshma V Amarsingh
Jingshu Xu
Sebastian Hogl
P2860
P2888
P356
10.1186/1475-2840-13-100
P407
P577
2014-06-14T00:00:00Z
P5875
P6179
1050303675